Enhancement of RNA Splicing by the Nutrient-Regulated Splicing Factor SRSF3

Total Page:16

File Type:pdf, Size:1020Kb

Enhancement of RNA Splicing by the Nutrient-Regulated Splicing Factor SRSF3 Graduate Theses, Dissertations, and Problem Reports 2015 Enhancement of RNA Splicing by the Nutrient-Regulated Splicing Factor SRSF3 Amanda L. Suchanek Follow this and additional works at: https://researchrepository.wvu.edu/etd Recommended Citation Suchanek, Amanda L., "Enhancement of RNA Splicing by the Nutrient-Regulated Splicing Factor SRSF3" (2015). Graduate Theses, Dissertations, and Problem Reports. 6740. https://researchrepository.wvu.edu/etd/6740 This Dissertation is protected by copyright and/or related rights. It has been brought to you by the The Research Repository @ WVU with permission from the rights-holder(s). You are free to use this Dissertation in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you must obtain permission from the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons license in the record and/ or on the work itself. This Dissertation has been accepted for inclusion in WVU Graduate Theses, Dissertations, and Problem Reports collection by an authorized administrator of The Research Repository @ WVU. For more information, please contact [email protected]. Enhancement of RNA Splicing by the Nutrient-Regulated Splicing Factor SRSF3. Amanda L. Suchanek Dissertation submitted to the School of Medicine at West Virginia University in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Biochemistry & Molecular Biology Committee Members Lisa Salati, Ph.D., Chair John Hollander, Ph.D. J. Michael Ruppert, M.D., Ph.D. Maxim Sokolov, Ph.D. Yehenew Agazie, Ph.D. Graduate Program in Biochemistry West Virginia University School of Medicine Morgantown, West Virginia 2015 Keywords: SRSF3, G6PD, RNA splicing, hepatocytes, adenovirus, intron retention © 2015 Amanda Suchanek ABSTRACT Enhancement of RNA Splicing by the Nutrient Regulated Splicing Factor, SRSF3 Amanda L. Suchanek Nutritional status is a powerful regulator of intracellular function. Dietary status can increase or decrease the rate of RNA splicing, thereby affecting gene expression; however, few molecular mechanisms have been identified that are responsible for this type of regulation. The glucose-6-phosphate dehydrogenase (G6PD) gene has provided a useful tool for the study of nutrient-regulated splicing because accumulation of G6PD mRNA is dependent solely on changes in the rate of mRNA splicing in response to nutritional stimuli, consistent with its enzymatic role of converting dietary energy to fatty acids. Treatment of primary hepatocytes in culture with insulin or feeding a high-carbohydrate, low fat diet to rodents increases splicing by 7- and 15-fold, respectively, and increases the cellular content of G6PD. In contrast, starvation or treatment of primary hepatocytes in culture with polyunsaturated fatty acids reduces G6PD mRNA splicing by 70% or more. The unspliced RNA is degraded in the nucleus, thus reducing expression of the G6PD enzyme. Our laboratory identified a splicing regulatory element within exon 12 of the G6PD transcript is required for splicing- related changes in G6PD expression in response to nutrient stimuli. This element is bound by two splicing regulatory proteins, SRSF3 and hnRNP K. To understand the mechanism of action of these proteins, we used a loss-of-function approach. SiRNA-mediated depletion of SRSF3 significantly decreased G6PD splicing and expression; in contrast, depletion of hnRNP K enhanced both splicing and mRNA accumulation. Consistent with their apparent roles as enhancers or silencers of splicing, respectively, the results of RNA immunoprecipitation (RIP) indicated binding of SRSF3 to exon 12 was enhanced 6-fold in the livers of refed mice and nearly undetectable in starved mice. Conversely, binding of hnRNP K to the regulatory element was increased 12.5-fold in the livers of starved mice and barely detectable in the livers of refed mice. Furthermore, RNA EMSA using purified SRSF3 and hnRNP K recombinant proteins, we demonstrated that SRSF3 and hnRNP K compete for binding to the same sequences within the regulatory element, which we hypothesize is a bifunctional ESE/ESS element. Thus, mutually exclusive binding of SRSF3 and hnRNP K to this regulatory element mediates the nutrient regulation of G6PD mRNA splicing and establishes a new intracellular mechanism for nutrient regulation of gene expression. We hypothesize that nutrient regulation of splicing is not unique to the G6PD mRNA, and thus the experiments described herein are focused identifying additional genes that are regulated by changes in alternative splicing in response to nutrient availability. ACKNOWLEDGMENTS I would like to thank all of the people who have stood by and supported me through this incredible journey. I’d like to thank my dissertation committee, and especially my advisor, Lisa Salati, for giving me a chance and for giving me the tools to be a successful research scientist. I’d also like to thank Brad Hillgartner, Roberta Leonardi, and Peter Stoilov for their advice and criticism during lab meetings and other presentations that have helped me become a stronger public speaker. I can say without hesitation that I would not have reached this point without the steadfast support of my family and friends. I’d first like to thank my father and mother, Joe & Cindy Suchanek, and my sister, Michelle Navarro, for always encouraging me to pursue my goals, for their emotional support and calming influences during the ups and downs of these last several years. I’d also like to thank my “Pennsylvania family,” especially my uncle Gary and aunt Cathy Robinson, cousins Cristen and Cris Lambert, and David, Tina, Jon, Jessi, and Courtney for their support (and Thanksgiving/Easter dinners!) while I have been pursuing this degree. I would like to thank my former lab mates Holly and Travis Cyphert for their friendship, advice, and our always exciting scientific discussions. I’d like to thank Jess Gibat and Kim Alonge for their friendship and support here in the biochemistry department. Our always- colorful conversations, scientific and otherwise, have gone a long way in keeping me sane. Thank you to my friends Gina Mazzetti, Rosemary and Jerry Munsey, without whom these final months spent finishing this degree would have been next to impossible. Finally, thank you to my other “sisters,” Alisa Elliott, Bahar Mihalcin, and Courtney Newhouse. Their unwavering support, encouragement, friendship, and laughter has kept me going through some of the toughest years of my life. iii TABLE OF CONTENTS LIST OF FIGURES vi. LIST OF ABBREVIATIONS viii. CHAPTER 1: LITERATURE REVIEW 1 I. RNA PROCESSING 1.1 INTRODUCTION 1 1.2 CAPPING 1 1.3 POLYADENYLATION 3 1.4 SPLICING 4 1.5 POST-SPLICING 8 1.6 ADDITIONAL SPLICING REGULATORY SEQUENCES 9 II. TYPES OF SPLICING 2.1 INTRODUCTION 10 2.2 ALTERNATIVE 5’ OR 3’ SPLICE SITE CHOICE 11 2.3 CASSETTE EXON SKIPPING/INCLUSION 15 2.4 INTRON RETENTION 16 III. REGULATION OF SPLICING 3.1 INTRODUCTION 17 3.2 hnRNPs 18 3.3 SR PROTEINS 20 3.4 REGULATION OF SR PROTEINS 22 3.5 SRSF3 AND REGULATION OF G6PD 24 IV. HYPOTHESIS 26 V. REFERENCES 27 CHAPTER 2: SERINE ARGININE SPLICING FACTOR 3 (SRSF3) IS INVOLVED IN ENHANCED SPLICING OF GLUCOSE-6- PHOSPHATE DEHYDROGENASE (G6PD) RNA IN RESPONSE TO NUTRIENTS AND HORMONES IN LIVER 42 CHAPTER 3: CONSTRUCTION AND EVALUATION OF AN ADENOVIRAL VECTOR FOR THE LIVER-SPECIFIC EXPRESSION OF THE SERINE/ARGININE-RICH SPLICING FACTOR, SRSF3 89 iv CHAPTER 4: INTRON RETENTION IS NOT A MAJOR REGULATOR OF HEPATIC GENE EXPRESSION 118 CHAPTER 5: SUMMARY 150 APPENDIX: I. CLIP-SEQ PROTOCOL 153 II. DUAL ISOLATION OF PROTEIN AND RNA FROM CELLS IN CULTURE 161 III. RNA IMMUNOPRECIPITATION PROTOCOL 164 v LIST OF FIGURES CHAPTER 1: Figure 1: mRNA and the spliceosome. 6 Figure 2: Splicing catalysis. 7 Figure 3: Types of splicing. 12-13 Figure 4: The SR protein family. 21 CHAPTER 2: Figure 1. Insulin and arachidonic acid regulate the amount of phosphorylated SR proteins in the nuclei of primary rat hepatocytes. 82 Figure 2. Refeeding increases the binding of phosphorylated SR proteins to the regulatory element of G6PD exon 12 in vivo. 83 Figure 3. SRSF3 and SRSF4 bind to the splicing regulatory element. 84 Figure 4. Purified SRSF3 binds to the regulatory element in exon 12. 85 Figure 5. SiRNA-mediated depletion of SRSF3 reduces the splicing of a G6PD reporter and the endogenous G6PD mRNA. 86 Figure 6. SiRNA-mediated depletion of SRSF3 reduces splicing of G6PD in HeLa cells. 87 Figure 7. SRSF3 specifically binds to the splicing regulatory element in vivo and refeeding enhances the binding of SRSF3 to the splicing regulatory element in mouse liver. 88 CHAPTER 3: Figure 1: Cloning schemes used to construct adenoviral shuttle vectors. 114 Figure 2: CMV-driven FLAG-SRSF3 is highly expressed in HEK293T packaging cells while albumin-driven FLAG-SRSF3 is not. 115 Figure 3: FLAG-SRSF3 is expressed in HepG2 cells infected with albumin FLAG-SRSF3 adenovirus. 115 vi Figure 4: FLAG-SRSF3 is detected in primary rat hepatocytes infected with albumin FLAG-SRSF3 adenovirus. 116 Figure 5: Overexpression of FLAG-SRSF3 regulates mRNA abundance of mRNA targets. 117 CHAPTER 4: Figure 1: Experimental approach. 129 a. Mouse experiment workflow. b. Agarose gel of total RNA collected from whole mouse liver. c. Representative BioAnalyzer traces of total RNA collected from whole mouse liver. Figure 2: qRT-PCR analysis of genes known to respond to starvation and refeeding. 129 Table 1a: Intron Retention Events (sorted
Recommended publications
  • Replace This with the Actual Title Using All Caps
    UNDERSTANDING THE GENETICS UNDERLYING MASTITIS USING A MULTI-PRONGED APPROACH A Dissertation Presented to the Faculty of the Graduate School of Cornell University In Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy by Asha Marie Miles December 2019 © 2019 Asha Marie Miles UNDERSTANDING THE GENETICS UNDERLYING MASTITIS USING A MULTI-PRONGED APPROACH Asha Marie Miles, Ph. D. Cornell University 2019 This dissertation addresses deficiencies in the existing genetic characterization of mastitis due to granddaughter study designs and selection strategies based primarily on lactation average somatic cell score (SCS). Composite milk samples were collected across 6 sampling periods representing key lactation stages: 0-1 day in milk (DIM), 3- 5 DIM, 10-14 DIM, 50-60 DIM, 90-110 DIM, and 210-230 DIM. Cows were scored for front and rear teat length, width, end shape, and placement, fore udder attachment, udder cleft, udder depth, rear udder height, and rear udder width. Independent multivariable logistic regression models were used to generate odds ratios for elevated SCC (≥ 200,000 cells/ml) and farm-diagnosed clinical mastitis. Within our study cohort, loose fore udder attachment, flat teat ends, low rear udder height, and wide rear teats were associated with increased odds of mastitis. Principal component analysis was performed on these traits to create a single new phenotype describing mastitis susceptibility based on these high-risk phenotypes. Cows (N = 471) were genotyped on the Illumina BovineHD 777K SNP chip and considering all 14 traits of interest, a total of 56 genome-wide associations (GWA) were performed and 28 significantly associated quantitative trait loci (QTL) were identified.
    [Show full text]
  • Miasdb: a Database of Molecular Interactions Associated with Alternative Splicing of Human Pre-Mrnas
    RESEARCH ARTICLE MiasDB: A Database of Molecular Interactions Associated with Alternative Splicing of Human Pre-mRNAs Yongqiang Xing1, Xiujuan Zhao1, Tao Yu2, Dong Liang1, Jun Li1, Guanyun Wei1, Guoqing Liu1, Xiangjun Cui1, Hongyu Zhao1, Lu Cai1* 1 School of Life Science and Technology, Inner Mongolia University of Science and Technology, Baotou, 014010, China, 2 School of Science, Inner Mongolia University of Science and Technology, Baotou, 014010, China a11111 * [email protected] Abstract Alternative splicing (AS) is pervasive in human multi-exon genes and is a major contributor to expansion of the transcriptome and proteome diversity. The accurate recognition of alter- OPEN ACCESS native splice sites is regulated by information contained in networks of protein-protein and Citation: Xing Y, Zhao X, Yu T, Liang D, Li J, Wei G, protein-RNA interactions. However, the mechanisms leading to splice site selection are not et al. (2016) MiasDB: A Database of Molecular fully understood. Although numerous databases have been built to describe AS, molecular Interactions Associated with Alternative Splicing of Human Pre-mRNAs. PLoS ONE 11(5): e0155443. interaction databases associated with AS have only recently emerged. In this study, we doi:10.1371/journal.pone.0155443 present a new database, MiasDB, that provides a description of molecular interactions Editor: Ruben Artero, University of Valencia, SPAIN associated with human AS events. This database covers 938 interactions between human splicing factors, RNA elements, transcription factors, kinases and modified histones for 173 Received: November 19, 2015 human AS events. Every entry includes the interaction partners, interaction type, experi- Accepted: April 28, 2016 mental methods, AS type, tissue specificity or disease-relevant information, a simple Published: May 11, 2016 description of the functionally tested interaction in the AS event and references.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • 1 AGING Supplementary Table 2
    SUPPLEMENTARY TABLES Supplementary Table 1. Details of the eight domain chains of KIAA0101. Serial IDENTITY MAX IN COMP- INTERFACE ID POSITION RESOLUTION EXPERIMENT TYPE number START STOP SCORE IDENTITY LEX WITH CAVITY A 4D2G_D 52 - 69 52 69 100 100 2.65 Å PCNA X-RAY DIFFRACTION √ B 4D2G_E 52 - 69 52 69 100 100 2.65 Å PCNA X-RAY DIFFRACTION √ C 6EHT_D 52 - 71 52 71 100 100 3.2Å PCNA X-RAY DIFFRACTION √ D 6EHT_E 52 - 71 52 71 100 100 3.2Å PCNA X-RAY DIFFRACTION √ E 6GWS_D 41-72 41 72 100 100 3.2Å PCNA X-RAY DIFFRACTION √ F 6GWS_E 41-72 41 72 100 100 2.9Å PCNA X-RAY DIFFRACTION √ G 6GWS_F 41-72 41 72 100 100 2.9Å PCNA X-RAY DIFFRACTION √ H 6IIW_B 2-11 2 11 100 100 1.699Å UHRF1 X-RAY DIFFRACTION √ www.aging-us.com 1 AGING Supplementary Table 2. Significantly enriched gene ontology (GO) annotations (cellular components) of KIAA0101 in lung adenocarcinoma (LinkedOmics). Leading Description FDR Leading Edge Gene EdgeNum RAD51, SPC25, CCNB1, BIRC5, NCAPG, ZWINT, MAD2L1, SKA3, NUF2, BUB1B, CENPA, SKA1, AURKB, NEK2, CENPW, HJURP, NDC80, CDCA5, NCAPH, BUB1, ZWILCH, CENPK, KIF2C, AURKA, CENPN, TOP2A, CENPM, PLK1, ERCC6L, CDT1, CHEK1, SPAG5, CENPH, condensed 66 0 SPC24, NUP37, BLM, CENPE, BUB3, CDK2, FANCD2, CENPO, CENPF, BRCA1, DSN1, chromosome MKI67, NCAPG2, H2AFX, HMGB2, SUV39H1, CBX3, TUBG1, KNTC1, PPP1CC, SMC2, BANF1, NCAPD2, SKA2, NUP107, BRCA2, NUP85, ITGB3BP, SYCE2, TOPBP1, DMC1, SMC4, INCENP. RAD51, OIP5, CDK1, SPC25, CCNB1, BIRC5, NCAPG, ZWINT, MAD2L1, SKA3, NUF2, BUB1B, CENPA, SKA1, AURKB, NEK2, ESCO2, CENPW, HJURP, TTK, NDC80, CDCA5, BUB1, ZWILCH, CENPK, KIF2C, AURKA, DSCC1, CENPN, CDCA8, CENPM, PLK1, MCM6, ERCC6L, CDT1, HELLS, CHEK1, SPAG5, CENPH, PCNA, SPC24, CENPI, NUP37, FEN1, chromosomal 94 0 CENPL, BLM, KIF18A, CENPE, MCM4, BUB3, SUV39H2, MCM2, CDK2, PIF1, DNA2, region CENPO, CENPF, CHEK2, DSN1, H2AFX, MCM7, SUV39H1, MTBP, CBX3, RECQL4, KNTC1, PPP1CC, CENPP, CENPQ, PTGES3, NCAPD2, DYNLL1, SKA2, HAT1, NUP107, MCM5, MCM3, MSH2, BRCA2, NUP85, SSB, ITGB3BP, DMC1, INCENP, THOC3, XPO1, APEX1, XRCC5, KIF22, DCLRE1A, SEH1L, XRCC3, NSMCE2, RAD21.
    [Show full text]
  • PRPF40A As a Potential Diagnostic and Prognostic Marker Is Upregulated in Pancreatic Cancer Tissues and Cell Lines: an Integrated Bioinformatics Data Analysis
    OncoTargets and Therapy Dovepress open access to scientific and medical research Open Access Full Text Article ORIGINAL RESEARCH PRPF40A as a potential diagnostic and prognostic marker is upregulated in pancreatic cancer tissues and cell lines: an integrated bioinformatics data analysis This article was published in the following Dove Press journal: OncoTargets and Therapy Zhen Huo* Background: Pre-mRNA processing factor 40 homolog A (PRPF40A) is an important Shuyu Zhai* protein involved in pre-mRNA splicing and is expressed in a variety of cell types. Yuanchi Weng* However, the function of PRPF40A in pancreatic cancer remains unclear. Therefore, our Hao Qian study is to investigate the role of PRPF40A in the pathogenesis of pancreatic cancer. Xiaomei Tang Materials and methods: We extracted expression data and clinical information of Yusheng Shi PRPF40A from different online databases, including the Cancer Genome Atlas (TCGA), Oncomine and the Gene Expression Omnibus (GEO). Subsequently, samples were collected Xiaxing Deng from patients to validate gene expression using qPCR, Western blotting and immunohisto- Yue Wang chemical (IHC) analyses. Receiver operating characteristic (ROC) and Kaplan-Meier curve Baiyong Shen were used to evaluate the diagnostic and prognostic potential. Colony formation assays and Department of General Surgery, Ruijin CCK-8 assays were performed to measure the proliferative capacity of pancreatic cancer. Hospital, Shanghai Jiao Tong University Finally, gene ontology (GO) and pathway enrichment analyses of co-expressed genes of School of Medicine, Shanghai 200025, People’s Republic of China PRPF40A were conducted using the Database for Annotation, Visualization and Integrated Discovery (DAVID). *These authors contributed equally to Results: We found that PRPF40A was upregulated based on data from both the online this work databases and our samples.
    [Show full text]
  • WO 2019/079361 Al 25 April 2019 (25.04.2019) W 1P O PCT
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization I International Bureau (10) International Publication Number (43) International Publication Date WO 2019/079361 Al 25 April 2019 (25.04.2019) W 1P O PCT (51) International Patent Classification: CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, C12Q 1/68 (2018.01) A61P 31/18 (2006.01) DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, C12Q 1/70 (2006.01) HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, (21) International Application Number: MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, PCT/US2018/056167 OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (22) International Filing Date: SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, 16 October 2018 (16. 10.2018) TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (25) Filing Language: English (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, (26) Publication Language: English GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, (30) Priority Data: UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, 62/573,025 16 October 2017 (16. 10.2017) US TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, ΓΕ , IS, IT, LT, LU, LV, (71) Applicant: MASSACHUSETTS INSTITUTE OF MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TECHNOLOGY [US/US]; 77 Massachusetts Avenue, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, Cambridge, Massachusetts 02139 (US).
    [Show full text]
  • Identification of Potential Key Genes and Pathway Linked with Sporadic Creutzfeldt-Jakob Disease Based on Integrated Bioinformatics Analyses
    medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Identification of potential key genes and pathway linked with sporadic Creutzfeldt-Jakob disease based on integrated bioinformatics analyses Basavaraj Vastrad1, Chanabasayya Vastrad*2 , Iranna Kotturshetti 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. 3. Department of Ayurveda, Rajiv Gandhi Education Society`s Ayurvedic Medical College, Ron, Karnataka 562209, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Abstract Sporadic Creutzfeldt-Jakob disease (sCJD) is neurodegenerative disease also called prion disease linked with poor prognosis. The aim of the current study was to illuminate the underlying molecular mechanisms of sCJD. The mRNA microarray dataset GSE124571 was downloaded from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) were screened.
    [Show full text]
  • Nuclear PTEN Safeguards Pre-Mrna Splicing to Link Golgi Apparatus for Its Tumor Suppressive Role
    ARTICLE DOI: 10.1038/s41467-018-04760-1 OPEN Nuclear PTEN safeguards pre-mRNA splicing to link Golgi apparatus for its tumor suppressive role Shao-Ming Shen1, Yan Ji2, Cheng Zhang1, Shuang-Shu Dong2, Shuo Yang1, Zhong Xiong1, Meng-Kai Ge1, Yun Yu1, Li Xia1, Meng Guo1, Jin-Ke Cheng3, Jun-Ling Liu1,3, Jian-Xiu Yu1,3 & Guo-Qiang Chen1 Dysregulation of pre-mRNA alternative splicing (AS) is closely associated with cancers. However, the relationships between the AS and classic oncogenes/tumor suppressors are 1234567890():,; largely unknown. Here we show that the deletion of tumor suppressor PTEN alters pre-mRNA splicing in a phosphatase-independent manner, and identify 262 PTEN-regulated AS events in 293T cells by RNA sequencing, which are associated with significant worse outcome of cancer patients. Based on these findings, we report that nuclear PTEN interacts with the splicing machinery, spliceosome, to regulate its assembly and pre-mRNA splicing. We also identify a new exon 2b in GOLGA2 transcript and the exon exclusion contributes to PTEN knockdown-induced tumorigenesis by promoting dramatic Golgi extension and secretion, and PTEN depletion significantly sensitizes cancer cells to secretion inhibitors brefeldin A and golgicide A. Our results suggest that Golgi secretion inhibitors alone or in combination with PI3K/Akt kinase inhibitors may be therapeutically useful for PTEN-deficient cancers. 1 Department of Pathophysiology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine (SJTU-SM), Shanghai 200025, China. 2 Institute of Health Sciences, Shanghai Institutes for Biological Sciences of Chinese Academy of Sciences and SJTU-SM, Shanghai 200025, China.
    [Show full text]
  • Supplementary Material Contents
    Supplementary Material Contents Immune modulating proteins identified from exosomal samples.....................................................................2 Figure S1: Overlap between exosomal and soluble proteomes.................................................................................... 4 Bacterial strains:..............................................................................................................................................4 Figure S2: Variability between subjects of effects of exosomes on BL21-lux growth.................................................... 5 Figure S3: Early effects of exosomes on growth of BL21 E. coli .................................................................................... 5 Figure S4: Exosomal Lysis............................................................................................................................................ 6 Figure S5: Effect of pH on exosomal action.................................................................................................................. 7 Figure S6: Effect of exosomes on growth of UPEC (pH = 6.5) suspended in exosome-depleted urine supernatant ....... 8 Effective exosomal concentration....................................................................................................................8 Figure S7: Sample constitution for luminometry experiments..................................................................................... 8 Figure S8: Determining effective concentration .........................................................................................................
    [Show full text]
  • Splice Variants As Novel Targets in Pancreatic Ductal Adenocarcinoma
    www.nature.com/scientificreports OPEN Splice variants as novel targets in pancreatic ductal adenocarcinoma Jun Wang1, Laurent Dumartin1, Andrea Mafficini 2, Pinar Ulug 1, Ajanthah Sangaralingam1, Namaa Audi Alamiry1, Tomasz P. Radon1, Roberto Salvia2, Rita T. Lawlor2, 1 2 1 1 Received: 10 March 2017 Nicholas R. Lemoine , Aldo Scarpa , Claude Chelala & Tatjana Crnogorac-Jurcevic Accepted: 26 April 2017 Despite a wealth of genomic information, a comprehensive alternative splicing (AS) analysis of Published: xx xx xxxx pancreatic ductal adenocarcinoma (PDAC) has not been performed yet. In the present study, we assessed whole exome-based transcriptome and AS profiles of 43 pancreas tissues using Affymetrix exon array. The AS analysis of PDAC indicated on average two AS probe-sets (ranging from 1–28) in 1,354 significantly identified protein-coding genes, with skipped exon and alternative first exon being the most frequently utilised. In addition to overrepresented extracellular matrix (ECM)- receptor interaction and focal adhesion that were also seen in transcriptome differential expression (DE) analysis, Fc gamma receptor-mediated phagocytosis and axon guidance AS genes were also highly represented. Of note, the highest numbers of AS probe-sets were found in collagen genes, which encode the characteristically abundant stroma seen in PDAC. We also describe a set of 37 ‘hypersensitive’ genes which were frequently targeted by somatic mutations, copy number alterations, DE and AS, indicating their propensity for multidimensional regulation. We provide the most comprehensive overview of the AS landscape in PDAC with underlying changes in the spliceosomal machinery. We also collate a set of AS and DE genes encoding cell surface proteins, which present promising diagnostic and therapeutic targets in PDAC.
    [Show full text]
  • Mrna Editing, Processing and Quality Control in Caenorhabditis Elegans
    | WORMBOOK mRNA Editing, Processing and Quality Control in Caenorhabditis elegans Joshua A. Arribere,*,1 Hidehito Kuroyanagi,†,1 and Heather A. Hundley‡,1 *Department of MCD Biology, UC Santa Cruz, California 95064, †Laboratory of Gene Expression, Medical Research Institute, Tokyo Medical and Dental University, Tokyo 113-8510, Japan, and ‡Medical Sciences Program, Indiana University School of Medicine-Bloomington, Indiana 47405 ABSTRACT While DNA serves as the blueprint of life, the distinct functions of each cell are determined by the dynamic expression of genes from the static genome. The amount and specific sequences of RNAs expressed in a given cell involves a number of regulated processes including RNA synthesis (transcription), processing, splicing, modification, polyadenylation, stability, translation, and degradation. As errors during mRNA production can create gene products that are deleterious to the organism, quality control mechanisms exist to survey and remove errors in mRNA expression and processing. Here, we will provide an overview of mRNA processing and quality control mechanisms that occur in Caenorhabditis elegans, with a focus on those that occur on protein-coding genes after transcription initiation. In addition, we will describe the genetic and technical approaches that have allowed studies in C. elegans to reveal important mechanistic insight into these processes. KEYWORDS Caenorhabditis elegans; splicing; RNA editing; RNA modification; polyadenylation; quality control; WormBook TABLE OF CONTENTS Abstract 531 RNA Editing and Modification 533 Adenosine-to-inosine RNA editing 533 The C. elegans A-to-I editing machinery 534 RNA editing in space and time 535 ADARs regulate the levels and fates of endogenous dsRNA 537 Are other modifications present in C.
    [Show full text]
  • Proteomics: a Tool to Study Platelet Function
    International Journal of Molecular Sciences Review Proteomics: A Tool to Study Platelet Function Olga Shevchuk 1,2,*, Antonija Jurak Begonja 3 , Stepan Gambaryan 4, Matthias Totzeck 5, Tienush Rassaf 5 , Tobias B. Huber 6, Andreas Greinacher 7, Thomas Renne 8 and Albert Sickmann 1,9,10,* 1 Leibniz-Institut für Analytische Wissenschaften—ISAS—e.V, Bunsen-Kirchhoff-Straße 11, 44139 Dortmund, Germany 2 Department of Immunodynamics, Institute of Experimental Immunology and Imaging, University Hospital Essen, Hufelandstrasse 55, 45147 Essen, Germany 3 Department of Biotechnology, University of Rijeka, Radmile Matejˇci´c2, 51000 Rijeka, Croatia; [email protected] 4 Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, Torez pr. 44, 194223 St. Petersburg, Russia; [email protected] 5 West German Heart and Vascular Center, Department of Cardiology and Vascular Medicine, University Hospital Essen, Hufelandstrasse 55, 45147 Essen, Germany; [email protected] (M.T.); [email protected] (T.R.) 6 III. Department of Medicine, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany; [email protected] 7 Institut für Immunologie und Transfusionsmedizin, Universitätsmedizin Greifswald, Sauerbruchstraße, 17475 Greifswald, Germany; [email protected] 8 Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany; [email protected] 9 Medizinisches Proteom-Center (MPC), Medizinische Fakultät, Ruhr-Universität Bochum, 44801 Bochum, Germany 10 Citation: Shevchuk, O.; Begonja, A.J.; Department of Chemistry, College of Physical Sciences, University of Aberdeen, Aberdeen AB24 3FX, UK * Correspondence: [email protected] (O.S.); [email protected] (A.S.) Gambaryan, S.; Totzeck, M.; Rassaf, T.; Huber, T.B.; Greinacher, A.; Renne, T.; Sickmann, A.
    [Show full text]